Postdoctoral Project Research Associate in Nanoparticle-based Targeted Therapy for Glioblastoma
The Department of Biochemistry at the All India Institute of Medical Sciences (AIIMS), Delhi, is seeking an experienced scientist for the position of Project Research Associate–III (PRA-III) to work on cutting-edge research in nanoparticle-based targeted therapy for glioblastoma. The research focuses on the design, development, and characterization of targeted nanoparticles, with applications in the treatment of glioblastoma, a highly aggressive brain tumor. Key responsibilities include in vitro and in vivo evaluation of nanoparticle-based therapeutic strategies, conducting molecular and cellular assays related to cancer biology, data analysis, interpretation, manuscript preparation, and coordination with multidisciplinary research teams.
Applicants must possess a PhD in Life Sciences, Biotechnology, Biochemistry, Nanotechnology, or a related discipline. Essential qualifications include proven hands-on experience with nanoparticle synthesis, functionalization, and characterization, as well as a strong background in cancer biology. Experience in glioblastoma research, cell culture, and molecular biology techniques is highly desirable. Candidates should also have a demonstrated publication record. Additional desirable skills include experience with targeted drug delivery systems, familiarity with in vivo tumor models, and the ability to work independently and mentor junior researchers.
The position is funded as per ICMR (PRA-III) guidelines, with eligibility and salary determined accordingly. The research environment at AIIMS offers access to state-of-the-art facilities and collaboration with leading experts in the field. This opportunity is ideal for postdoctoral researchers aiming to advance their careers in nanotechnology, cancer biology, and biomedical engineering.
Interested candidates should send their CV and a brief statement of research experience to Professor Kunzang Chosdol at [email protected] by 1st January 2026, 5pm. For more information, refer to the LinkedIn profile provided.